A year of Execution, Foundation Building, and International ExpansionKINGSVILLE, ON, Jan. 5, 2026 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis for the Canadian market, is pleased to provide a review of its operational and strategic progress throughout 2025, a year defined by disciplined execution, continued efficiency gains, and the successful launch of the Company's international wholesale ...

Proven tobacco, pharmaceutical, and cannabis executive will lead the Company’s enterprise-wide strategic agenda Appointment underscores the Company’s commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Co ...

Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar LTM revenue and 2.4x LTM EBITDA2 Will give Cronos #1 market share3 in the largest adult-use cannabis market in Europe Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cr ...

Core Insights - FLUENT Corp. has rebranded its Manhattan and White Plains dispensaries, marking the second and third adult-use locations in New York under the FLUENT brand [1][3] - The rebranding follows FLUENT's acquisition of RIV Capital and aims to enhance the company's presence in the rapidly growing adult-use cannabis market in the U.S. [3] Group 1: Rebranding and Market Strategy - The rebranding of the three dispensaries is expected to drive positive results in traffic, sales volume, and average ticket sales [3] - FLUENT is committed to creating a consistent and trusted retail experience across its locations, which is crucial for its New York strategy [4] - The company is preparing for the first harvest from its new indoor cultivation facility in Buffalo, with premium flower expected to be available in Q4 [4] Group 2: Digital Integration and Product Offerings - All three rebranded dispensaries are fully integrated into FLUENT's digital platform, allowing customers to browse products and place orders online [4] - The dispensaries feature FLUENT's premium cannabis brands, including MOODS, Knack, Wandr, Alien Labs, and Connected Cannabis [6][7] Group 3: Company Overview - FLUENT is a national cannabis consumer packaged goods company operating in Florida, New York, Pennsylvania, and Texas, with a focus on operational excellence [7] - The company employs 700 staff across 8 cultivation and manufacturing facilities and has 42 active retail locations [7] - FLUENT's common shares trade on the Canadian Securities Exchange and the OTCQB Venture Market [8]

Core Insights - Tilray Brands (TLRY) is set to report its first-quarter fiscal 2026 results on October 9, 2025, before market opening [1] - The company reported fourth-quarter fiscal 2025 adjusted earnings of 2 cents per share, exceeding the Zacks Consensus Estimate by 166.67% [1] - TLRY has beaten earnings estimates in two of the last four quarters and missed in the other two [1] Revenue and Earnings Estimates - The Zacks Consensus Estimate for revenues in the upcoming quarter is $206.8 million, indicating a 3.4% increase from the previous year [2] - The loss per share estimate is set at 3 cents, reflecting a 25% year-over-year increase [2] - Estimates for loss per share have remained unchanged at 3 cents over the past 30 days [3] Factors Influencing Performance - **Cannabis Segment**: In the fourth quarter of fiscal 2025, cannabis net revenues declined year-over-year due to a pause in vape and infused pre-roll categories and delays in international medical cannabis permits. However, international cannabis revenues reached a record high of $22.4 million, with Germany showing 134% growth [4] - **Tilray Medical**: The division introduced three new medical cannabis flower varieties in Italy, becoming the first authorized company to import and distribute its products there. A strategic partnership with Molteni aims to enhance the availability of Tilray Medical cannabis extracts in Italy, expected to boost top-line growth [5] Segment Performance Expectations - **Beverages**: The Beverages segment is anticipated to see a revenue decline due to SKU rationalization under Project 420. However, the Breckenridge Distillery brand is expected to show resilience in the bourbon sector [8][10] - **Wellness**: The Wellness segment is projected to experience a year-over-year revenue surge, driven by the growth of Manitoba Harvest Hemp Hearts and new product innovations [11] - **Distribution**: Distribution revenues, primarily from Tilray Pharma, are expected to grow due to changes in product mix [12] Earnings Outlook - Tilray Brands has an Earnings ESP of 0.00%, indicating no expected earnings surprise for the upcoming report [13] - The company currently holds a Zacks Rank of 3, suggesting a neutral outlook [13]

Core Insights - Canopy Growth Corporation has transitioned its DOJA facility in Kelowna, British Columbia to operate exclusively as a medical cultivation site [1] - The Kelowna facility will focus on cultivating small-batch, BC-grown craft cannabis to support the Company's Spectrum Therapeutics portfolio in Canada [1] Company Developments - The decision to operate the DOJA facility solely for medical purposes aligns with Canopy Growth's commitment to enhancing the therapeutic potential of cannabis [1] - The shift to small-batch cultivation emphasizes quality and local sourcing, which may enhance the brand's reputation in the medical cannabis market [1]

Core Viewpoint - InterCure Ltd. is acquiring Botanico Ltd. (known as ISHI) to enhance its global cannabis portfolio and gain access to premium American cultivation technology and brand partnerships, coinciding with potential regulatory changes in the cannabis industry [1][6]. Group 1: Acquisition Details - The acquisition will provide InterCure with ISHI's advanced AI-driven cultivation technologies, automated production systems, and exclusive brand alliances with leading U.S. operators [2]. - The deal is structured in two phases: InterCure will initially purchase 50% of ISHI's equity for 2.47 million ordinary shares, with the remaining 50% to be acquired upon ISHI achieving sustained profitability for three months or within two years, in exchange for an additional 2.46 million shares [4]. - The total deal represents approximately 10% of InterCure's fully diluted outstanding stock, with closing expected in the first quarter of 2026, pending regulatory approvals in Israel [4]. Group 2: Strategic Implications - The acquisition allows InterCure to immediately access award-winning American cannabis genetics and operational expertise through partnerships, including one with The Flowery, a prominent medical cannabis firm in Florida [3]. - ISHI's co-founders will join InterCure's leadership team, and all employee stock options at ISHI will convert to InterCure options under existing vesting terms, facilitating integration [5]. - This strategic move is viewed as a significant milestone by InterCure's CEO, positioning the company to leverage regulatory momentum and exclusive access to U.S. brands [6].

As filed with the Securities and Exchange Commission on September 18, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Akanda Corp. (Exact name of Registrant as specified in its charter) Ontario, Canada 2833 Not Applicable FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Akanda Corp. c/o Gowling WLG (Canada) LLP 100 King St. ...

Core Insights - Village Farms International, Inc. reported strong financial results for Q2 2025, highlighting record profitability levels since entering the cannabis sector in 2017, with significant growth in adjusted EBITDA and net income [3][4][9]. Financial Performance - Consolidated net sales increased by 12% to $59.9 million from $53.6 million year-over-year [4][9]. - Consolidated net income was $26.5 million, or $0.24 per share, compared to a net loss of $23.5 million, or ($0.21) per share in the prior year [4][9]. - Adjusted EBITDA from continuing operations reached $17.1 million, representing 28.6% of sales, marking a significant increase from $2.9 million in the previous year [4][9]. - Canadian cannabis adjusted EBITDA surged by 146% year-over-year, reflecting successful margin improvement initiatives [4][9]. Strategic Developments - The company completed a transformative transaction on May 30, 2025, privatizing certain assets and operations of its Produce segment, receiving $40 million in cash and a 37.9% equity interest in Vanguard Food LP [2][4]. - The privatized operations are now classified as discontinued operations, with financial results adjusted for comparative periods [2][4]. - Village Farms maintains a top three market share position in Canada and the number one position in dried flower sales year-to-date through July 2025 [8]. Operational Highlights - The company has commenced sales in the Netherlands' adult-use market and is expanding its cannabis cultivation capacity in Canada and the Netherlands [3][4]. - International medical export sales increased by 690% year-over-year, driven by new customer relationships and increased sales from existing customers [14][20]. - The company achieved a gross margin of 39%, up from 26% in the previous year, primarily due to the increase in international sales [4][9]. Future Outlook - Village Farms anticipates continued profitable growth in 2026 and beyond, supported by capacity expansion projects and a strong balance sheet [3][4]. - The company plans to leverage its experience in controlled environment agriculture to capitalize on emerging cannabis opportunities globally [18][20].

Core Insights - GrowGeneration Corp. has entered into a distribution agreement with V1 Solutions to expand its market presence in the European Union and Costa Rica, targeting the growing demand for hydroponic and organic gardening products [1][2][4] Group 1: EU Expansion - The partnership with V1 Solutions will leverage their strategic relationships with commercial cultivators in Europe, allowing GrowGen to meet the increasing demand for advanced cultivation products as cannabis regulations evolve [2][4] - Target markets in the EU include Germany, Portugal, Malta, Luxembourg, the Netherlands, Czech Republic, Greece, and Macedonia, all of which are experiencing significant cannabis cultivation developments [7] Group 2: Central America Expansion - GrowGen has launched its proprietary brands in Costa Rica, which has issued over 50 licenses for hemp and cannabis production in the past year, positioning it as a key growth market in Central America [3][4] - The favorable growing conditions and developing export infrastructure in Costa Rica enhance its potential for cannabis cultivation [3] Group 3: Product Offerings - GrowGen will supply its proprietary brands, including Drip Hydro, Char Coir, Ion Lighting, Power Si, and The Harvest Company, to commercial cultivators, garden centers, and licensed operators in the targeted regions [2][4] Group 4: International Strategy - The company is exploring additional markets in Eastern Europe and Latin America, aiming to serve high-growth regions through local partnerships and product education [4] - GrowGeneration's international sales infrastructure and regulatory expertise position it well to capitalize on the cannabis cultivation boom in regions with advancing legalization [4]